Personal information

No personal information available

Activities

Collapse all

Employment (1)

Affiliated Hospital of Xuzhou Medical University: Xuzhou, CN

2006-08-01 to present (hematology)
Employment
Source: Self-asserted source
Wei Sang

Education and qualifications (1)

Nanjing Medical University: Nanjing, Jiangsu, CN

2011-09-01 to 2015-07-01 | PhD (hematology)
Education
Source: Self-asserted source
Wei Sang

Professional activities (1)

Chinese Anti-Cancer Association: Tianjin, CN

2019-05-01 to present | committee member (lymphoma)
Membership
Source: Self-asserted source
Wei Sang

Funding (1)

Natural Science Foundation of Jiangsu Province

Grant
Natural Science Foundation of Jiangsu Province (Xuzhou, CN)
GRANT_NUMBER:

BK20171181
Source: Self-asserted source
Wei Sang

Works (50 of 55)

Items per page:
Page 1 of 2

The prognostic value of controlling nutritional status (CONUT) score–based nomogram on extranodal natural killer/T cell lymphoma patients

Annals of Hematology
2023-06 | Journal article
DOI: 10.1007/s00277-023-05232-3
Part of ISSN: 0939-5555
Part of ISSN: 1432-0584
Contributors: Shuo Zhang; Cai Sun; Xicheng Chen; Dashan Li; Lingling Hu; Meng Zhang; Xudong Zhang; Hao Zhang; Jingjing Ye; Ling Wang et al.
Source: Self-asserted source
Wei Sang

Thymosin β4 exerts cytoprotective function and attenuates liver injury in murine hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation

Transplantation and Cellular Therapy
2023-05 | Journal article
DOI: 10.1016/j.jtct.2023.05.009
Part of ISSN: 2666-6367
Contributors: Xiangmin Wang; Yi Zhou; Qian Sun; Qing Zhang; Hongyuan Zhou; Jiaoli Zhang; Yuwei Du; Yuhan Wang; Ke Yuan; Linyan Xu et al.
Source: Self-asserted source
Wei Sang

Anti–G Protein–Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial

Journal of Clinical Oncology
2023-05-10 | Journal article
DOI: 10.1200/jco.22.01824
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: Jieyun Xia; Hujun Li; Zhiling Yan; Dian Zhou; Ying Wang; Yuekun Qi; Jiang Cao; Depeng Li; Hai Cheng; Wei Sang et al.
Source: Self-asserted source
Wei Sang

A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells

Frontiers in Immunology
2023-04-19 | Journal article
DOI: 10.3389/fimmu.2023.1169071
Part of ISSN: 1664-3224
Contributors: Yang Liu; Xingxing Jie; Li Nian; Ying Wang; Congyue Wang; Jin Ma; Jingjing Jiang; Qingyun Wu; Jianlin Qiao; Wei Chen et al.
Source: Self-asserted source
Wei Sang

Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma

Journal of Infection and Chemotherapy
2023-02 | Journal article
DOI: 10.1016/j.jiac.2022.10.012
Part of ISSN: 1341-321X
Contributors: Dian Zhou; Ying Wang; Hai Cheng; Lili Zhu; Wei Chen; Hujun Li; Xiaotian Zhang; Jieyun Xia; Yuekun Qi; Sha Ma et al.
Source: Self-asserted source
Wei Sang

Prognostic value of prognostic nutritional index on extranodal natural killer/T‐cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working Group

Hematological Oncology
2023-01-29 | Journal article
DOI: 10.1002/hon.3124
Part of ISSN: 0278-0232
Part of ISSN: 1099-1069
Contributors: Ziyuan Shen; Shuo Zhang; Xicheng Chen; Qing Zhang; Yaxue Jiao; Yuye Shi; Hao Zhang; Jingjing Ye; Ling Wang; Taigang Zhu et al.
Source: Self-asserted source
Wei Sang

Disparity analysis of clinical features and prognostic evaluation of hemophagocytic lymphohistiocytosis in pediatric and adult patients: a retrospective multicenter study of 525 cases in HHLWG

Acta Haematologica
2023-01-09 | Journal article
DOI: 10.1159/000528934
Part of ISSN: 0001-5792
Part of ISSN: 1421-9662
Contributors: Xiangmin Wang; Yi Zhou; Qian Sun; Hongyuan Zhou; Qing Zhang; Ziyuan Shen; Jie Huang; Yao Xue; Dongmei Yan; Yongjun Fang et al.
Source: Self-asserted source
Wei Sang

Disparity Analysis of Clinicopathologic Hallmarks between Transformed DLBCL and Primary DLBCL

Clinical Laboratory
2022 | Journal article
DOI: 10.7754/clin.lab.2021.211028
Part of ISSN: 1433-6510
Contributors: Cai Sun; Ziyuan Shen; Zhenzhen Bian; Yuanyuan Ma; Jiaqin Li; Yuhan Ma; Xuguang Song; Dongmei Yan; Hui Liu; Zhenyu Li et al.
Source: Self-asserted source
Wei Sang

Clinicopathologic Features and Genomic Signature of De Novo CD5+ Diffuse Large B-Cell Lymphoma

American Journal of Surgical Pathology
2022-11 | Journal article
DOI: 10.1097/pas.0000000000001957
Part of ISSN: 0147-5185
Contributors: Wei Sang; Yuhan Ma; Xiangmin Wang; Yuanyuan Ma; Ziyuan Shen; Weiying Gu; Fei Wang; Jingjing Ye; Cuijuan Zhang; Yuqing Miao et al.
Source: Self-asserted source
Wei Sang

Editorial: Pathogenesis, immune escape, prognosis, and novel management of lymphoid proliferative disorders

Frontiers in Immunology
2022-11-21 | Journal article
DOI: 10.3389/fimmu.2022.1063418
Part of ISSN: 1664-3224
Contributors: Wei Sang
Source: Self-asserted source
Wei Sang

Value of the prognostic nutritional index ( <scp>PNI</scp> ) in patients with newly diagnosed, <scp>CD5</scp> ‐positive diffuse large B‐cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working Group

Cancer
2022-10 | Journal article | Author
DOI: 10.1002/cncr.34405
Part of ISSN: 0008-543X
Part of ISSN: 1097-0142
Contributors: Sha Ma; Bingpei Zhang; Tianyi Lu; Dashan Li; Tianci Li; Ziyuan Shen; Chenlu He; Ying Wang; Bingzong Li; Hao Zhang et al.
Source: Self-asserted source
Wei Sang

LASSO Model Better Predicted the Prognosis of DLBCL than Random Forest Model: A Retrospective Multicenter Analysis of HHLWG

Journal of Oncology
2022-09-16 | Journal article | Author
DOI: 10.1155/2022/1618272
Part of ISSN: 1687-8469
Part of ISSN: 1687-8450
Contributors: Given Names Deactivated Family Name Deactivated; Shuo Zhang; Yaxue Jiao; Yuye Shi; Hao Zhang; Fei Wang; Ling Wang; Taigang Zhu; Yuqing Miao; Wei Sang et al.
Source: Self-asserted source
Wei Sang

Visceral fat area and albumin based nutrition-related prognostic index model could better stratify the prognosis of diffuse large B-cell lymphoma in rituximab era

Frontiers in Nutrition
2022-09-08 | Journal article
DOI: 10.3389/fnut.2022.981433
Part of ISSN: 2296-861X
Contributors: Ziyuan Shen; Lingling Hu; Shuo Zhang; Qian Sun; Weidong Li; Dongmei Yan; Guoqi Cai; Wei Sang
Source: Self-asserted source
Wei Sang

<scp>l</scp> ‐Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein−Barr virus‐positive Burkitt lymphoma

Journal of Biochemical and Molecular Toxicology
2022-08 | Journal article
DOI: 10.1002/jbt.23117
Part of ISSN: 1095-6670
Part of ISSN: 1099-0461
Contributors: Wei Sang; Dongyun Tu; Meng Zhang; Yuanyuan Qin; Wenjing Yin; Xuguang Song; Cai Sun; Dongmei Yan; Xiangmin Wang; Lingyu Zeng et al.
Source: Self-asserted source
Wei Sang

Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx

Frontiers in Oncology
2022-08-23 | Journal article
DOI: 10.3389/fonc.2022.941347
Part of ISSN: 2234-943X
Contributors: Dongshen Ma; Yuhan Ma; Yuanyuan Ma; Jia Liu; Ying Gu; Nian Liu; Chenxi Xiang; Hui Liu; Wei Sang
Source: Self-asserted source
Wei Sang

Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma

Journal of Clinical Oncology
2022-07-10 | Journal article
DOI: 10.1200/jco.21.01676
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: kailin xu; Jiang Cao; Weiying Gu; Ming Shi; Jianping Lan; Zhiling Yan; Lai Jin; Jieyun Xia; Sha Ma; Yang Liu et al.
Source: Self-asserted source
Wei Sang

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Blood
2022-06-09 | Journal article | Author
DOI: 10.1182/blood.2021013733
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Contributors: Yuekun Qi; Mingfeng Zhao; Yongxian Hu; Ying Wang; Ping Li; Jiang Cao; Ming Shi; Jiaqi Tan; Meng Zhang; Xia Xiao et al.
Source: Self-asserted source
Wei Sang

The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma

Anti-Cancer Agents in Medicinal Chemistry
2022-05 | Journal article
DOI: 10.2174/1871520621666210908103306
Part of ISSN: 1871-5206
Contributors: Wei Sang; Kailin Xu; Linyan Xu; Yuanyuan Qin; Mengdi Liu; Jun Jiao; Dongyun Tu; Meng Zhang; Dongmei Yan; Xuguang Song et al.
Source: Self-asserted source
Wei Sang

Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma

Frontiers in Immunology
2022-04-01 | Journal article
DOI: 10.3389/fimmu.2022.858021
Part of ISSN: 1664-3224
Contributors: Wei Sang; Xiangmin Wang; Hongzhi Geng; Tianci Li; Dashan Li; Bingpei Zhang; Yi Zhou; Xuguang Song; Cai Sun; Dongmei Yan et al.
Source: Self-asserted source
Wei Sang
grade
Preferred source (of 2)‎

CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase

Frontiers in Immunology
2022-03-17 | Journal article
DOI: 10.3389/fimmu.2022.829366
Part of ISSN: 1664-3224
Contributors: Jing Yang; Pengfei Li; Yingshi Piao; Xindi Liu; Liqiang Wei; Wei Sang; Luo Zhang; Liang Wang
Source: Self-asserted source
Wei Sang

A Novel Prognostic Index Model for Adult Hemophagocytic Lymphohistiocytosis: A Multicenter Retrospective Analysis in China

Frontiers in Immunology
2022-02-18 | Journal article
DOI: 10.3389/fimmu.2022.829878
Part of ISSN: 1664-3224
Contributors: Ziyuan Shen; Yingliang Jin; Qian Sun; Shuo Zhang; Xi Chen; Lingling Hu; Chenlu He; Ying Wang; Qinhua Liu; Hao Zhang et al.
Source: Self-asserted source
Wei Sang
grade
Preferred source (of 2)‎

Correction to: Irradiation induces homing of donor endothelial progenitor cells in allogeneic hematopoietic stem cell transplantation

International Journal of Hematology
2022-01 | Journal article
DOI: 10.1007/s12185-021-03268-7
Part of ISSN: 0925-5710
Part of ISSN: 1865-3774
Contributors: Lingyu Zeng; Shuang Ding; Zhiling Yan; Chong Chen; Wei Sang; Jiang Cao; Hai Cheng; Kailin Xu
Source: Self-asserted source
Wei Sang

The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B‐Cell Lymphoma

Frontiers in Oncology
2022-01-19 | Journal article
DOI: 10.3389/fonc.2021.823079
Part of ISSN: 2234-943X
Contributors: Ziyuan Shen; Shuo Zhang; Meng Zhang; Lingling Hu; Qian Sun; Chenlu He; Dongmei Yan; Jingjing Ye; Hao Zhang; Ling Wang et al.
Source: Self-asserted source
Wei Sang

Disparity analysis and prognostic value of pretreatment whole blood <scp>Epstein‐Barr</scp> virus <scp>DNA</scp> load and Epstein‐Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group

International Journal of Cancer
2022-01-15 | Journal article | Author
DOI: 10.1002/ijc.33802
Part of ISSN: 0020-7136
Part of ISSN: 1097-0215
Contributors: Ziyuan Shen; Lingling Hu; Mingkang Yao; Chenlu He; Qinhua Liu; Fei Wang; Weiying Gu; Ying Wang; Manyu Dong; Taigang Zhu et al.
Source: Self-asserted source
Wei Sang

EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells

Journal of Cancer
2021 | Journal article
DOI: 10.7150/jca.48310
Part of ISSN: 1837-9664
Contributors: Linyan Xu; Xiang Gao; Pu Yang; Wei Sang; Jun Jiao; Mingshan Niu; Mengdi Liu; Yuanyuan Qin; Dongmei Yan; Xuguang Song et al.
Source: Self-asserted source
Wei Sang

Prognostic values of geriatric nutritional risk index (GNRI) and prognostic nutritional index (PNI) in elderly patients with Diffuse Large B-Cell Lymphoma

Journal of Cancer
2021 | Journal article
DOI: 10.7150/jca.62340
Part of ISSN: 1837-9664
Contributors: Dongmei Yan; Ziyuan Shen; Shuo Zhang; Lingling Hu; Qian Sun; Kailin Xu; Yingliang Jin; Wei Sang
Source: Self-asserted source
Wei Sang

Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China

Frontiers in Oncology
2021-11-03 | Journal article
DOI: 10.3389/fonc.2021.754180
Part of ISSN: 2234-943X
Contributors: Ziyuan Shen; Ling Wang; Bingpei Zhang; Tianci Li; Dashan Li; Chenlu He; Yuhao Xue; Ying Wang; Bingzong Li; Qinhua Liu et al.
Source: Self-asserted source
Wei Sang

The Value of Prognostic Nutritional Index (PNI) on Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: A Multicenter Retrospective Study of HHLWG Based on Propensity Score Matched Analysis

Journal of Inflammation Research
2021-10 | Journal article
DOI: 10.2147/jir.s340822
Part of ISSN: 1178-7031
Contributors: Ziyuan Shen; Fei Wang; Chenlu He; Dashan Li; Shanlin Nie; zz370826 Bian; Mingkang Yao; Yuhao Xue; Ying Wang; Weiying Gu et al.
Source: Self-asserted source
Wei Sang

Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy

Frontiers in Immunology
2021-10-29 | Journal article
DOI: 10.3389/fimmu.2021.755549
Part of ISSN: 1664-3224
Contributors: Wei Chen; Yuhan Ma; Ziyuan Shen; Huimin Chen; Ruixue Ma; Dongmei Yan; Ming Shi; Xiangmin Wang; Xuguang Song; Cai Sun et al.
Source: Self-asserted source
Wei Sang

Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era

International Journal of Hematology
2021-08 | Journal article
DOI: 10.1007/s12185-021-03145-3
Part of ISSN: 0925-5710
Part of ISSN: 1865-3774
Contributors: Wei Sang; Hang Zhou; Yuanyuan Qin; Ziyuan Shen; Dongmei Yan; Cai Sun; Xuguang Song; Yuhan Ma; Dongyun Tu; Zhenzhen Bian et al.
Source: Self-asserted source
Wei Sang

An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective Study

Frontiers in Oncology
2021-06-14 | Journal article
DOI: 10.3389/fonc.2021.691064
Part of ISSN: 2234-943X
Contributors: Kunming Qi; Zhiling Yan; Hai Cheng; Wei Chen; Ying Wang; Xue Wang; Jiang Cao; Huanxin Zhang; Wei Sang; Feng Zhu et al.
Source: Self-asserted source
Wei Sang

Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

Advances in Therapy
2021-04 | Journal article
DOI: 10.1007/s12325-020-01603-8
Part of ISSN: 0741-238X
Part of ISSN: 1865-8652
Contributors: Yuqin Song; Hui Zhou; Huilai Zhang; Wei Liu; Yuerong Shuang; Keshu Zhou; Fangfang Lv; Hao Xu; Jianfeng Zhou; Wei Li et al.
Source: Self-asserted source
Wei Sang

Kinetics of immune reconstitution after anti‐CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients

International Journal of Laboratory Hematology
2021-04 | Journal article
DOI: 10.1111/ijlh.13375
Part of ISSN: 1751-5521
Part of ISSN: 1751-553X
Contributors: Ying Wang; Hujun Li; Xuguang Song; Kunming Qi; Hai Cheng; Jiang Cao; Ming Shi; Zhiling Yan; Guangjun Jing; Bin Pan et al.
Source: Self-asserted source
Wei Sang

Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma

Transplantation and Cellular Therapy
2021-03 | Journal article
DOI: 10.1016/j.jtct.2020.12.017
Part of ISSN: 2666-6367
Contributors: Wei Chen; Ying Wang; Kunming Qi; Ming Shi; Jiang Cao; Rahul Bhansali; Xue Wang; Yang Liu; Hujun Li; Huanxin Zhang et al.
Source: Self-asserted source
Wei Sang

Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Treatment

Frontiers in Immunology
2021-02-23 | Journal article
DOI: 10.3389/fimmu.2021.611366
Part of ISSN: 1664-3224
Contributors: Zhiling Yan; Huanxin Zhang; Jiang Cao; Cheng Zhang; Hui Liu; Hongming Huang; Hai Cheng; Jianlin Qiao; Ying Wang; Yan Wang et al.
Source: Self-asserted source
Wei Sang

Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment

Bone Marrow Transplantation
2020-11 | Journal article
DOI: 10.1038/s41409-020-0930-5
Part of ISSN: 0268-3369
Part of ISSN: 1476-5365
Contributors: Hujun Li; Lingling Yin; Ying Wang; Xiangmin Wang; Ming Shi; Jiang Cao; Zhiling Yan; Wei Sang; Hai Cheng; Feng Zhu et al.
Source: Self-asserted source
Wei Sang

Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection

Leukemia
2020-10 | Journal article
DOI: 10.1038/s41375-020-0936-4
Part of ISSN: 0887-6924
Part of ISSN: 1476-5551
Contributors: Ying Wang; Yang Liu; Xu Tan; Bin Pan; Jian Ge; Kunming Qi; Hai Cheng; Jiang Cao; Ming Shi; Zhiling Yan et al.
Source: Self-asserted source
Wei Sang

Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma

Cancer Medicine
2020-08 | Journal article | Author
DOI: 10.1002/cam4.3259
Part of ISSN: 2045-7634
Part of ISSN: 2045-7634
Contributors: Wei Sang; Ming Shi; Jingjing Yang; Jiang Cao; Linyan Xu; Dongmei Yan; Meixue Yao; Hui Liu; Weidong Li; Bing Zhang et al.
Source: Self-asserted source
Wei Sang

Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies

Biology of Blood and Marrow Transplantation
2020-05 | Journal article
DOI: 10.1016/j.bbmt.2019.11.027
Part of ISSN: 1083-8791
Contributors: Ying Wang; Kunming Qi; Hai Cheng; Jiang Cao; Ming Shi; Jianlin Qiao; Zhiling Yan; Guangjun Jing; Bin Pan; Wei Sang et al.
Source: Self-asserted source
Wei Sang

TIRC7 inhibits Th1�cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease

Oncology Reports
2020-04-21 | Journal article
DOI: 10.3892/or.2020.7588
Part of ISSN: 1021-335X
Part of ISSN: 1791-2431
Contributors: Feng Zhu; Tingting Qiu; Shengyun Zhu; Kai Zhao; Chong Chen; Jianlin Qiao; Bin Pan; Zhiling Yan; Wei Chen; Qiong Liu et al.
Source: Self-asserted source
Wei Sang

A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial

The Lancet Haematology
2019-10 | Journal article
DOI: 10.1016/s2352-3026(19)30115-2
Part of ISSN: 2352-3026
Contributors: Zhiling Yan; Jiang Cao; Hai Cheng; Jianlin Qiao; Huanxin Zhang; Ying Wang; Ming Shi; Jianping Lan; Xiaoming Fei; Lai Jin et al.
Source: Self-asserted source
Wei Sang

Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

American Journal of Hematology
2018-07 | Journal article
DOI: 10.1002/ajh.25108
Part of ISSN: 0361-8609
Contributors: Jiang Cao; Gang Wang; Hai Cheng; Chen Wei; Kunming Qi; Wei Sang; Li Zhenyu; Ming Shi; Huizhong Li; Jianlin Qiao et al.
Source: Self-asserted source
Wei Sang

Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations

Annals of Hematology
2017-11 | Journal article
DOI: 10.1007/s00277-017-3093-8
Part of ISSN: 0939-5555
Part of ISSN: 1432-0584
Contributors: Mingshan Niu; Yangling Shen; Jialei Qi; Xuejiao Liu; Wei Sang; Qingyun Wu; Jiang Cao; Wei Chen; Yao Yao; Kailin Xu
Source: Self-asserted source
Wei Sang

Plumbagin reduces chronic lymphocytic leukemia cell survival by downregulation of Bcl-2 but upregulation of the Bax protein level

Oncology Reports
2016-09 | Journal article
DOI: 10.3892/or.2016.4950
Part of ISSN: 1021-335X
Part of ISSN: 1791-2431
Contributors: Chunling Fu; Yanqing Gong; Xuanxuan Shi; Zengtian Sun; Mingshan Niu; Wei Sang; Linyan Xu; Feng Zhu; Ying Wang; Kailin Xu
Source: Self-asserted source
Wei Sang

MicroRNA-150 negatively regulates the function of CD4+ T cells through AKT3/Bim signaling pathway

Cellular Immunology
2016-08 | Journal article
DOI: 10.1016/j.cellimm.2016.05.007
Part of ISSN: 0008-8749
Contributors: Wei Sang; Cai Sun; Cong Zhang; Dianzheng Zhang; Ying Wang; Linyan Xu; Zhe Zhang; Xiangyu Wei; Bin Pan; Dongmei Yan et al.
Source: Self-asserted source
Wei Sang

Fludarabine, idarubicin, and cytarabine regimen together with <scp>TKI</scp> followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia

Clinical Case Reports
2016-04 | Journal article
DOI: 10.1002/ccr3.438
Part of ISSN: 2050-0904
Part of ISSN: 2050-0904
Contributors: Wei Sang; Ying Wang; Cong Zhang; Dongmei Yan; Mingshan Niu; Chun Yang; Xia Liu; Cai Sun; Zhe Zhang; Thomas P. Loughran et al.
Source: Self-asserted source
Wei Sang

MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway

Immunology Letters
2016-04 | Journal article
DOI: 10.1016/j.imlet.2015.11.001
Part of ISSN: 0165-2478
Contributors: Wei Sang; Ying Wang; Cong Zhang; Dianzheng Zhang; Cai Sun; Mingshan Niu; Zhe Zhang; Xiangyu Wei; Bin Pan; Wei Chen et al.
Source: Self-asserted source
Wei Sang

Cytotoxic T Lymphocyte Antigen-4 Down-Regulates T Helper 1 Cells by Increasing Expression of Signal Transducer and Activator of Transcription 3 in Acute Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation
2016-02 | Journal article
DOI: 10.1016/j.bbmt.2015.11.003
Part of ISSN: 1083-8791
Contributors: Feng Zhu; Xiao-Min Zhong; Jianlin Qiao; Qiong Liu; Hai-Ying Sun; Wei Chen; Kai Zhao; Qing-Yun Wu; Jiang Cao; Wei Sang et al.
Source: Self-asserted source
Wei Sang

MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production

American Journal of Hematology
2015-11 | Journal article
DOI: 10.1002/ajh.24136
Part of ISSN: 0361-8609
Contributors: Wei Sang; Cong Zhang; Dianzheng Zhang; Ying Wang; Cai Sun; Mingshan Niu; Xiaoshen Sun; Cui Zhou; Lingyu Zeng; Bin Pan et al.
Source: Self-asserted source
Wei Sang
grade
Preferred source (of 2)‎

Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP)

Thrombosis Research
2015-10 | Journal article
DOI: 10.1016/j.thromres.2015.07.017
Part of ISSN: 0049-3848
Contributors: Feng Zhu; Jianlin Qiao; Jiang Cao; Hai-ying Sun; Qing-yun Wu; Zeng-tian Sun; Kai Zhao; Wei Sang; Kun-ming Qi; Ling-yu Zeng et al.
Source: Self-asserted source
Wei Sang
Items per page:
Page 1 of 2
How many people are using ORCID?